Inventor · Hertford, GB

Pascal Merchiers

19Patents

3h-index

14Co-inventors

49Inventor score

Filing activity: Mar 3, 2018 → Nov 30, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US10738125B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	10	Active
US10752691B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	10	Active
US10745485B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	10	Active
US11236173B2	CD38 antibody	Chemistry; Metallurgy	1	Active
US11542338B2	CD38 modulating antibody	Chemistry; Metallurgy	1	Active
US11787866B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	0	Active
US12161717B2	CD38 modulating antibody agents	Chemistry; Metallurgy	0	Active
US11780930B2	CD38 modulating antibody	Chemistry; Metallurgy	0	Active
US11919960B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	0	Active
US11851494B2	Anti-CD25 for tumour specific cell depletion	Chemistry; Metallurgy	0	Active
US11873341B2	Anti-CD25 for tumour specific cell depletion	Chemistry; Metallurgy	0	Active
US11814434B2	Anti-CD25 for tumour specific cell depletion	Chemistry; Metallurgy	0	Active
US12304964B2	CD38 modulating antibody	Chemistry; Metallurgy	0	Active
US11879014B2	Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody	Chemistry; Metallurgy	0	Active
US12162949B2	CD38 antibody	Chemistry; Metallurgy	0	Active
US11802161B2	Anti-CD25 for tumour specific cell depletion	Chemistry; Metallurgy	0	Active
US11802160B2	Anti-CD25 antibody agents	Chemistry; Metallurgy	0	Active
US11697688B2	Anti-CD25 for tumour specific cell depletion	Chemistry; Metallurgy	0	Active
US12343394B2	CD38 modulating antibody agents	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.